Literature DB >> 20477617

Role of macrophages in HIV infection and persistence.

Stephanie Venzke1, Oliver T Keppler.   

Abstract

Current antiretroviral therapy regimens can effectively suppress HIV in patients for prolonged periods of time, but do not constitute a cure, since they are incapable of eradicating viral reservoirs. It is, therefore, necessary for us to refocus on the partially understood pathogenesis of HIV, on the issue of viral persistence, and on the development of strategies for a temporally contained therapy capable of purging HIV from the body. Macrophages play a pivotal role in all three of these scenarios. This review summarizes important aspects of macrophage biology as they relate to HIV and discusses conceptual challenges for virus suppression and eradication in this cell type. We highlight a number of significant recent advances in understanding differences in HIV replication and pharmacotherapy between macrophages and CD4 T cells, as well as the role of macrophages in various aspects of the disease process and in different anatomical compartments. Finally, the importance of infected macrophages in the persistence of HIV, regarding both pathogenesis and advancement of eradication strategies, is discussed.

Entities:  

Year:  2006        PMID: 20477617     DOI: 10.1586/1744666X.2.4.613

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  15 in total

1.  HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Authors:  Christine Goffinet; Ina Allespach; Oliver T Keppler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-05       Impact factor: 11.205

2.  Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages.

Authors:  Sonja Welsch; Fedde Groot; Hans-Georg Kräusslich; Oliver T Keppler; Quentin J Sattentau
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

3.  High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.

Authors:  Hanna-Mari Tervo; Oliver T Keppler
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 4.  Targeting viral reservoirs: ability of antiretroviral therapy to stop viral replication.

Authors:  Frank Maldarelli
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

5.  HIV-1 uses dynamic podosomes for entry into macrophages.

Authors:  Wei Li; Ji Liu; Yuanyuan Liu; Qin Li; Wen Yin; Kevin K Wanderi; Xiaowei Zhang; Zhiping Zhang; Xian-En Zhang; Zongqiang Cui
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

6.  Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo.

Authors:  Christine Goffinet; Ina Allespach; Lena Oberbremer; Pamela L Golden; Scott A Foster; Brian A Johns; Jason G Weatherhead; Steven J Novick; Karen E Chiswell; Edward P Garvey; Oliver T Keppler
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

7.  HIV-1 buds predominantly at the plasma membrane of primary human macrophages.

Authors:  Sonja Welsch; Oliver T Keppler; Anja Habermann; Ina Allespach; Jacomine Krijnse-Locker; Hans-Georg Kräusslich
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

Review 8.  Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.

Authors:  Xiaoyu Pan; Hanna-Mari Baldauf; Oliver T Keppler; Oliver T Fackler
Journal:  Cell Res       Date:  2013-06-04       Impact factor: 25.617

9.  Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.

Authors:  Nico Michel; Christine Goffinet; Kerstin Ganter; Ina Allespach; Vineet N Kewalramani; Mohammed Saifuddin; Dan R Littman; Warner C Greene; Mark A Goldsmith; Oliver T Keppler
Journal:  Retrovirology       Date:  2009-01-13       Impact factor: 4.602

10.  Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.

Authors:  Christine Goffinet; Nico Michel; Ina Allespach; Hanna-Mari Tervo; Volker Hermann; Hans-Georg Kräusslich; Warner C Greene; Oliver T Keppler
Journal:  Retrovirology       Date:  2007-07-26       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.